First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-08-21 15:33:23 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41591-026-04564-7
文献链接: https://www.nature.com/articles/s41591-026-04564-7
其他信息:
出版社: Springer Science and Business Media LLC
作者: Xiying Shao; Can Tian; Zhanhong Chen; Jian Huang; Yongsheng Wang; Tao Sun; Tienan Yi; Yifen Wu; Weihua Sun; Xufang Yu; Zhongmin Maxwell Wang; Baiyong Li; Yu Xia; Xiaojia Wang; Quchang Ouyang
全文下载地址: https://www.nature.com/articles/s41591-026-04564-7.pdf

